Issue |
E3S Web Conf.
Volume 477, 2024
International Conference on Smart Technologies and Applied Research (STAR'2023)
|
|
---|---|---|
Article Number | 00059 | |
Number of page(s) | 15 | |
DOI | https://doi.org/10.1051/e3sconf/202447700059 | |
Published online | 16 January 2024 |
Antioxidant Effects of Rutin Trihydrate vs. Doxorubicin in Zebrafish Larvae: GSH, GPx, and GST Activity
Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, Tamil Nadu, Pincode- 602105.
* Corresponding author: saishababadjanova@gmail.com
This study aimed to compare the clinical relevance of the novel drug rutin trihydrate with doxorubicin concerning their influence on the antioxidant enzymes GST, GPX, and GSH. Zebrafish larvae were subjected to oxidative stress induced by H₂O₂ at 1mM concentration, and their antioxidant activity was assessed through enzymatic assays. The stock solution was prepared with DMSO, and zebrafish eggs were collected in a 1:1 male-to-female breeding ratio, followed by distribution into four petri plates for exposure to rutin trihydrate from 4 hours post-fertilization (hpf) to 96 hpf. Hatching rates were recorded after 96 hpf, and SPSS software was utilized for statistical analysis. Embryos exposed to compound dosage exhibited significantly increased enzyme activity (p < 0.000, p < 0.05) (8.5667.17593) compared to appropriate dosages (34.40000.07). With a total sample size of 30 and parameters including a 0.05 significance threshold, 80% statistical power, a 95% confidence interval, and an enrolment ratio of 1, the study revealed notable alterations in GPX (9%), GSH (5%), and GST (5%) activity in zebrafish larvae treated with rutin trihydrate and doxorubicin. The investigation’s significance level was determined to be p = 0.000 (p < 0.05), signifying a statistically significant difference among the test groups. These findings shed light on the potential clinical implications of these compounds on zebrafish larvae’s antioxidant systems.
Key words: Novel drug Rutin Trihydrate / Doxorubicin / ROS / Enzyme / Zebrafish / Diseases
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.